Affimed N V (AFMD)

Nov 15, 2024

Affimed N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024

Nov 15, 2024

Stifel Nicolaus Cuts Affimed (NASDAQ:AFMD) Price Target to $4.00 - MarketBeat

Nov 15, 2024

Nov 15, 2024

Affimed N.V. (NASDAQ:AFMD) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 15, 2024

Affimed's (AFMD) Buy Rating Reiterated at HC Wainwright - MarketBeat

Nov 15, 2024

Nov 15, 2024

Earnings call: Affimed reports promising results and strategic focus - Investing.com India

Nov 15, 2024

Nov 15, 2024

Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating F - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges with ... - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

Affimed Reports Q3 2024 Financial Results and Updates - TipRanks

Nov 14, 2024

Nov 14, 2024

Affimed N.V.: Q3 Earnings Snapshot - Milford Mirror

Nov 14, 2024

Nov 14, 2024

Affimed NV earnings missed by €0.09, revenue fell short of estimates - Investing.com Canada

Nov 14, 2024

Nov 14, 2024

Affimed Faces Growing Losses Amid Financial Struggles - TipRanks

Nov 14, 2024

Nov 14, 2024

Affimed Reports Third Quarter 2024 Financial Results & Business Update - The Manila Times

Nov 14, 2024

Nov 14, 2024

Affimed N.V.: Q3 Earnings Snapshot | National Business News | voiceofalexandria.com - Voice Of Alexandria

Nov 14, 2024

Nov 14, 2024

Affimed Q3 Revenue Drops 90%, but Net Loss Narrows as R&D Costs Decline | AFMD Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

Affimed (AFMD) Scheduled to Post Quarterly Earnings on Thursday - Defense World

Nov 13, 2024

Nov 07, 2024

Affimed to Report Third Quarter 2024 Financial Results and Corporate Update on November 14, 2024 - Marketscreener.com

Nov 07, 2024

Nov 07, 2024

Affimed (AFMD) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 07, 2024

Nov 06, 2024

Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024 - GlobeNewswire

Nov 06, 2024

Nov 06, 2024

Affimed (AFMD) Sets Q3 2024 Earnings Call for Nov 14: Immuno-Oncology Updates Ahead | AFMD Stock News - StockTitan

Nov 06, 2024

Nov 06, 2024

Affimed (NASDAQ:AFMD) Share Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat

Nov 06, 2024

Nov 06, 2024

Affimed Announces Acceptance of Three Abstracts at the 2024 - GlobeNewswire

Nov 06, 2024

Nov 05, 2024

Affimed to Present Promising AML Treatment Data at ASH 2024 Annual Meeting | AFMD Stock News - StockTitan

Nov 05, 2024

Oct 28, 2024

Affimed (NASDAQ:AFMD) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Oct 28, 2024

Oct 28, 2024

Affimed (NASDAQ:AFMD) Given Average Rating of “Buy” by Analysts - Defense World

Oct 28, 2024

Oct 27, 2024

Affimed (NASDAQ:AFMD) Short Interest Update - MarketBeat

Oct 27, 2024

Oct 24, 2024

683 Capital Management, LLC Expands Stake in Affimed NV - Yahoo Finance

Oct 24, 2024

Oct 15, 2024

Affimed Appoints New Director Amid Strategic Moves - TipRanks

Oct 15, 2024

Oct 15, 2024

Affimed N : Annual General Meeting Results Form 6 K - Marketscreener.com

Oct 15, 2024

Oct 04, 2024

Affimed N : Presentation - Marketscreener.com

Oct 04, 2024

Oct 03, 2024

Analysts Set Affimed (NASDAQ:AFMD) Target Price at $20.00 - MarketBeat

Oct 03, 2024

Sep 30, 2024

Affimed Appoints New CEO, Shares Fall on Leadership Change - MSN

Sep 30, 2024

Sep 21, 2024

Affimed appoints Shawn Leland as chief executive officer - MSN

Sep 21, 2024

Sep 17, 2024

Affimed (NASDAQ:AFMD) Sees Significant Decrease in Short Interest - MarketBeat

Sep 17, 2024

Sep 13, 2024

AFMDAffimed N.V. Latest Stock News & Market Updates - StockTitan

Sep 13, 2024

Sep 12, 2024

Affimed N.V. Announces Upcoming EGM - TipRanks

Sep 12, 2024

Sep 10, 2024

Affimed to Present at the Cantor Global Healthcare Conference 2024 - GlobeNewswire

Sep 10, 2024

Sep 10, 2024

Affimed (NASDAQ:AFMD) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World

Sep 10, 2024

Sep 09, 2024

Cantor Fitzgerald Reiterates "Overweight" Rating for Affimed (NASDAQ:AFMD) - MarketBeat

Sep 09, 2024

Sep 08, 2024

Affimed (NASDAQ:AFMD) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Sep 08, 2024

Sep 07, 2024

Affimed N.V. (NASDAQ:AFMD) Q2 2024 Earnings Call Transcript - Insider Monkey

Sep 07, 2024

Sep 06, 2024

HC Wainwright Reaffirms Buy Rating for Affimed (NASDAQ:AFMD) - MarketBeat

Sep 06, 2024

Sep 06, 2024

Earnings call: Affimed reports promising clinical results and stable finances By Investing.com - Investing.com Australia

Sep 06, 2024

Sep 06, 2024

Earnings call: Affimed reports promising clinical results and stable finances - Investing.com

Sep 06, 2024

Sep 06, 2024

Affimed NV (AFMD) Q2 2024 Earnings Call Transcript Highlights: F - GuruFocus.com

Sep 06, 2024

Sep 06, 2024

Affimed N.V.: Q2 Earnings Snapshot - New Haven Register

Sep 06, 2024

Sep 05, 2024

Affimed to Present Preclinical Data Demonstrating Cytotoxic Activity of its Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA) - Yahoo Finance UK

Sep 05, 2024

Sep 05, 2024

Stifel holds Affimed at $5 target with new CEO at helm By Investing.com - Investing.com Canada

Sep 05, 2024

Sep 05, 2024

Stifel holds Affimed at $5 target with new CEO at helm - Investing.com

Sep 05, 2024